Company Name : Alexandria Pharmaceuticals ISIN Code : EGS38341C011 Currency : EGP F/S Period : From 01/07/2023 To 30/09/2023 Net Profit : 59,181,903 F/S Period: From 01/07/2022 To 30/09/2022 Net Comparative Profit : 34,586,874 Audit Status : Reviewed Source : Alexandria Pharmaceuticals The Financial Statements (6,667 KB) The Financial Statements (6,667 KB)